1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-94004, E-2894, NCI-T93-0198D, T93-0198
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-30951, NCT00002737
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: COG-A3973, CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, NCT00004188, A3973
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-3723, ICC-82L4, NCI-V83-0135
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: MDA-DM-8489, NCI-V85-0151
|
|
7.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor:
Protocol IDs: DCPC-CPSB-10305
|
|
8.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCOG-CC7H871J, RTOG-8910, NCI-C88-0001
|
|
9.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: 21 to less than 85
Sponsor:
Protocol IDs: UARIZ-P89-0002, NCI-P89-0002
|
|
10.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: 21 to less than 85
Sponsor:
Protocol IDs: UARIZ-CA34256, NCI-P89-0004
|
|
11.
|
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 to 74
Sponsor: NCI
Protocol IDs: RTOG-9115, CLB-9499, SWOG-9446, MDA-CCOP-DM-90094, NCI-P91-0024, NCI-C91-0002, RTOG-91-15, MDA-C91-0002
|
|
12.
|
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91025, CLB-9293, E-91025, NCCTG-912452, RTOG-9101, SWOG-9221, I91-0001, INT-0125, NCI-P92-0014
|
|
13.
|
Phase: Phase III
Type: Prevention
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: EST-C-0590, MAYO-887451, NCCTG-887451, NCI-P92-0026
|
|
14.
|
Phase: Phase III
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MDA-DM-90096, NCI-V93-0310
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-1301, E1301, NCT00054561
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 21 at diagnosis
Sponsor: NCI
Protocol IDs: COG-ACNS0231, ACNS0231, NCT00078988
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI
Protocol IDs: COG-ANBL0531, ANBL0531, NCT00499616
|
|
18.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI
Protocol IDs: COG-ANBL0532, ANBL0532, NCT00567567
|
|
19.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: COG-ANBL0931, ANBL0931, NCT01041638
|
|
20.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CBRG-9508, NBSG-9508, NCI-V96-0834
|
|
21.
|
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 50-84
Sponsor: NCI
Protocol IDs: MDA-ID-95184, NCI-P97-0099
|
|
22.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: UNM-0996C, NCI-V98-1478, NCT00003585
|
|
23.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 to 90
Sponsor: Other
Protocol IDs: AUH-MCP-70612-01, AUH-MCP-70612-02P, NCI-V98-1485, NCT00003619
|
|
24.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: NCI
Protocol IDs: EST-PC-483, EST-P-C483
|
|
25.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: NCI
Protocol IDs: UARIZ-8567, NCI-T85-0215D, T85-0215
|
Mobile | Español
